Exposure to sibutramine during pregnancy: a case series

被引：10

作者：

Einarson, A ^{[1
]}

Bonari, L ^{[1
]}

Sarkar, M ^{[1
]}

McKenna, K ^{[1
]}

Koren, G ^{[1
]}

机构：

[1] Univ Toronto, Hosp Sick Children, Div Clin Pharmacol, Motherisk Program, Toronto, ON M5G 1X8, Canada

来源：

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 2004年 / 116卷 / 01期

关键词：

D O I：

10.1016/j.ejogrb.2004.02.035

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

[No abstract available]

引用

页码：112 / 112

页数：1

共 5 条

[1] THE PHARMACOLOGY OF SIBUTRAMINE HYDROCHLORIDE (BTS54524), A NEW ANTIDEPRESSANT WHICH INDUCES RAPID NORADRENERGIC DOWN-REGULATION [J].

BUCKETT, WR ;

THOMAS, PC ;

LUSCOMBE, GP .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1988, 12 (05) :575-584

[2] Sibutramine: its mode of action and efficacy [J].

Finer, N .

INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (Suppl 4) :S29-S33

[3] Effect of sibutramine on weight maintenance after weight loss:: a randomised trial [J].

James, WPT ;

Astrup, A ;

Finer, N ;

Hilsted, J ;

Kopelman, P ;

Rössner, S ;

Saris, WHM ;

Van Gaal, LF .

LANCET, 2000, 356 (9248) :2119-2125

[4] The discovery and status of sibutramine as an anti-obesity drug [J].

Luque, CA ;

Rey, JA .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) :119-128

[5]

2002, MERIDIA PRODUCT MONO

← 1 →